No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BSX250117C90000
- 5.60
- +0.40+7.69%
15min DelayClose Jan 14 16:00 ET
6.00High5.12Low
5.50Open5.20Pre Close658 Volume6.36K Open Interest90.00Strike Price350.02KTurnover35.35%IV-0.05%PremiumJan 17, 2025Expiry Date5.65Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9793Delta0.0172Gamma16.78Leverage Ratio-0.0289Theta0.0064Rho16.43Eff Leverage0.0041Vega
Intraday
- 5D
- Daily
News
CardioFocus Announces Publication of 1-Year ECLIPSE AF Clinical Trial Results
Boston Scientific Expects Farapulse, Watchman to Drive 2025 Growth
Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $107
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Why Boston Scientific (BSX) Is Skyrocketing in 2025?
Baird Adjusts Price Target on Boston Scientific $104 From $102, Keeps Outperform Rating